seanpavone
Sean Pavone / Shutterstock.com
4 June 2020Asia

Rouse and Codex launch new China partnership

IP firm  Rouse will collaborate with life sciences service provider  Codex to support companies looking to enter the Chinese market.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Big Pharma
27 February 2020   US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration.
Americas
18 June 2020   MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.

More on this story

Americas
18 June 2020   MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
Asia
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Big Pharma
27 February 2020   US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration.

More on this story

Americas
18 June 2020   MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
Asia
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.
Big Pharma
27 February 2020   US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration.